Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Akebia Therapeutics (AKBA) Treasury Stock (2014 - 2016)

Updated

Akebia Therapeutics' Treasury Shares came in at $162,000 for Q1 2016, up 0.6% from $161,000 a year earlier and unchanged from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Treasury Stock (2014 - 2016) Analysis & Trends

Going back to Q2 2014, Akebia Therapeutics' Treasury Shares data covers 8 quarters.

  • Going back by year, Treasury Shares was $162,000 in FY2014.
  • Year-over-year, Treasury Shares increased in three of the last four quarters, with growth averaging 191.0%.
  • Business Quant data shows AKBA's Treasury Shares at $162,000 (Q4 2015), $162,000 (Q3 2015) and $162,000 (Q2 2015) in the three quarters before Q1 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Stock (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -3.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 76.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.62 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 64.59 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.20 Bn
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 162,000.00
Dec 31, 2015 162,000.00
Sep 30, 2015 162,000.00
Jun 30, 2015 162,000.00
Mar 31, 2015 161,000.00
Dec 31, 2014 162,000.00
Sep 30, 2014 79,000.00
Jun 30, 2014 21,362.00
API Access

Akebia Therapeutics Treasury Stock API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=AKBA&period=max&api_key=YOUR_API_KEY